
The World Health Organization has approved the first mpox diagnostic test, the Alinity m MPXV assay by Abbott Laboratories, for emergency use. The PCR test detects mpox virus DNA from human skin lesion swabs, expanding access to critical medical testing. WHO is also evaluating three additional diagnostic tools and collaborating with manufacturers like Roche and Labcorp to enhance testing capacity. The emergency use listing (EUL) process expedites the availability of unlicensed diagnostics, vaccines, and therapeutics during public health crises.
Like
Save
Share